“How do you do electronics with graphene? How should that be approached from a standardization point of view? Specifically, what should the standards be around an electronics grade mono-layer CVD (Chemical Vapor Deposition) graphene?” asks Brett Goldsmith, PhD, Chief Technology Officer at Cardea, and continues, “Graphene has phenomenal properties as biosensors, meaning that graphene is going to change the world and how we interact with biology as human beings. But making graphene work reliably is much harder than I think a lot of us understood in the beginning. Standards are important for that and what the Graphene Council is doing, is important for that.”
The Graphene Council is the largest community in the world for graphene researchers, academics, producers, developers, investors, nanotechnologists, regulatory agencies, research institutes, and material science specialists. The Graphene Council is a member of the ISO/ANSI TC 229 Nanotechnology Standards Development Group and the IEC TC 113, Nano-Electrotechnologies Technical Committee.
Executive Director at the Graphene Council, Terrance Barkan, adds “On the standards side, Cardea has been a huge help for us in understanding the needs for this particular type of graphene for electronics. Cardea has gone several steps further to target what graphene can do with its amazing properties to solve really significant problems. Personally, I can't think of many areas more meaningful than human health and diagnostics.”
Dr. Goldsmith continues, “This year has seen a maturation of the conversation in relation to the industry and graphene standards and in working on the standards side, I've been super impressed with the Graphene Council. As an industry it’s great to see us mature like this and really take the end-product focus-point of view on what we're doing. The standard will likely become a bit more complicated when it's going to be used in a biosensor for medicine, but the philosophy is the same: Get all the way through your application, through to the end-customer, before you think you know your input material!”
The entire interview is freely available here.
News page specific
10. January 2023
Previously unachievable drug discovery insights created by Cardea’s BPU platformToday, Cardea Bio, Inc. reaches an 8-year milestone of the first external partner starting to use the BPU (Biosignal Processing Unit) platform for advancing drug discovery research to produce new and highly sought-after...
20. December 2022
Graphene for electronics making strides towards ISO standards - spearheaded by MITO and CardeaSan Diego, California -- December 20, 2022 -- MITO® Material Solutions and Cardea Bio, Inc. are pleased to announce significant progress in the international efforts to standardize graphene together with the National...
25. August 2022
SRC invites Cardea to be part of defining how to integrate biology with electronicsSan Diego, California -- August 25, 2022 -- As part of the Semiconductor Research Corporation (SRC) being selected by NIST’s Advanced Manufacturing Office to define the future of Microelectronics and Advanced Packaging...
16. August 2022